52w high/low | ₹582.3 / ₹265.3 |
P/E ratio | 12.06 |
Dividend | 0 |
ROE | 11.36 |
ROCE | 15.24 |
Face value | 10 |
Book value | ₹570.15Cr |
Market capital | ₹278.96Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Coral Laboratories Limited has been promoted by Navin B Doshi of the DWD group. The Company is spearheaded by Kishor R Mehta as Executive Director. CLL produces various pharmaceutical formulations. To Manufacture pharmaceutical formulations like tablets,capsules the company went into public issue in March 94 at a total cost of Rs. 2. 5 crores. The project has been completed successfully CLL plans to expand its activities in the present premises by foraying into the sophisticated FFS (form fill and seal) technology for injections. The machinery for the said technology will be imported.